Figure 1. Best overall percentage change from baseline in target tumor lesion measurements. Percentage changes are shown as waterfall plots for 30 evaluable patients treated with CP-870,893 in combination with carboplatin and paclitaxel with two dose levels on two schedules. Data do not reflect new lesions.